Immunomonitoring of MSC-Treated GvHD Patients Reveals Only Moderate Potential for Response Prediction but Indicates Treatment Safety - Concepedia

Concepedia

Publication | Open Access

Immunomonitoring of MSC-Treated GvHD Patients Reveals Only Moderate Potential for Response Prediction but Indicates Treatment Safety

DOI Full Paper Access

27

Citations

28

References

2018

Year

Joni Keto, Tanja Kaartinen, Urpu Salmenniemi, Johanna Castrén, Jukka Partanen, Arno Hänninen, Matti Korhonen, Kaarina Lähteenmäki, Maija Itälä‐Remes, Johanna Nystedt

Molecular Therapy — Methods & Clinical Development

References

	Year	Citations

Page 1